Innovent Announces NMPA Approval of Limertinib, a Third-generation EGFR TKI Collaborated with ASK Pharma, for the First-line Treatment of Lung Cancer SAN FRANCISCO and SUZHOU,China, April 26, 2025 /PRNewswire/ — Innovent Biologics, Inc.… CISION PRNewswireApril 26, 2025
Concord Medical Files Annual Report on Form 20-F for Fiscal 2024 BEIJING, April 26, 2025 /PRNewswire/ — Concord Medical Services Holdings Limited ("Concord… CISION PRNewswireApril 26, 2025
Zepp Health Corporation Files 2024 Annual Report on Form 20-F MILPITAS, Calif., April 26, 2025 /PRNewswire/ — Zepp Health Corporation ("Zepp Health"… CISION PRNewswireApril 26, 2025
Press ReleaseAmcor to report fiscal 2025 third quarter results ZURICH, April 26, 2025 /PRNewswire/ — Amcor plc ("Amcor") (NYSE: AMCR, ASX:… CISION PRNewswireApril 26, 2025
Webull Files Annual Report on Form 20-F for Year Ended December 31, 2024 ST. PETERSBURG, Fla., April 26, 2025 /PRNewswire/ — Webull Corporation (NASDAQ: BULL)… CISION PRNewswireApril 26, 2025
MDJM LTD Announces Receipt of Nasdaq Delisting Determination and Plan to Request a Hearing before the Nasdaq Hearings Panel LETHAM, Scotland, April 26, 2025 /PRNewswire/ — MDJM LTD (Nasdaq: UOKA) (the… CISION PRNewswireApril 26, 2025
Press ReleaseVivienne Westwood dazzles at Barcelona Bridal Night with an epic show In the cloister of the historic building of the University of Barcelona… CISION PRNewswireApril 26, 2025
Press ReleaseBLUETTI Apex 300 and Full Ecosystem In-Person Debut at Media Day: Innovation Meets Sustainability SHENZHEN, China, April 26, 2025 /PRNewswire/ — Global clean energy leader BLUETTI, unveiled… CISION PRNewswireApril 26, 2025
